A share price of Repligen Corp [RGEN] is currently trading at $158.01, up 2.98%. An important factor to consider is whether the stock is rising or falling in short-term value. The RGEN shares have gain 8.34% over the last week, with a monthly amount glided 6.48%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Repligen Corp [NASDAQ: RGEN] stock has seen the most recent analyst activity on October 01, 2025, when HSBC Securities initiated its Buy rating and assigned the stock a price target of $150. Previously, Evercore ISI upgraded its rating to Outperform on September 22, 2025, and kept the price target unchanged to $155. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $150 on June 24, 2025. Wolfe Research upgraded its rating to a Outperform but $160 remained the price target by the analyst firm on April 29, 2025. Evercore ISI started tracking with a In-line rating for this stock on March 18, 2025, and assigned it a price target of $155. In a note dated February 10, 2025, TD Cowen initiated an Buy rating and provided a target price of $200 on this stock.
Repligen Corp experienced fluctuations in its stock price throughout the past year between $102.96 and $182.52. Currently, Wall Street analysts expect the stock to reach $171 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $158.01 at the most recent close of the market. An investor can expect a potential return of 8.22% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
Trailing Twelve Months sales for Repligen Corp [NASDAQ:RGEN] were 707.89M which represents 21.91% growth. Gross Profit Margin for this corporation currently stands at 0.48% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.0 and Total Capital is 0.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 154.17 points at the first support level, and at 150.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 160.29, and for the 2nd resistance point, it is at 162.58.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Repligen Corp [NASDAQ:RGEN] is 8.36. On the other hand, the Quick Ratio is 7.14, and the Cash Ratio is 5.71. Considering the valuation of this stock, the price to sales ratio is 12.56, the price to book ratio is 4.27 and price to earnings (TTM) ratio is 6148.25.
Transactions by insiders
Recent insider trading involved Hunt Anthony, Director, that happened on Nov 12 ’25 when 25000.0 shares were purchased. Director, Hunt Anthony completed a deal on Sep 10 ’25 to sell 29111.0 shares. Meanwhile, Director Hunt Anthony bought 29111.0 shares on Sep 10 ’25.
